![Breaking Science in Gastrointestinal Cancers with Giovanni Randon – ESMO](https://oncodaily.com/pub/uploads/2024/07/1721995314353-e1722117987474.png)
Photo from ESMO/LinkedIn
Jul 28, 2024, 10:33
Breaking Science in Gastrointestinal Cancers with Giovanni Randon – ESMO
ESMO – European Society for Medical Oncology shared on LinkedIn:
“For ESMO members: Breaking Science in Gastrointestinal Cancers.
Giovanni Randon presents Switch maintenance with ramucirumab plus paclitaxel in advanced HER2-negative gastric/GEJ cancer.
Discover this video and more in the series on OncologyPRO now.”
Source: ESMO/LinkedIn